TNF Pharmaceuticals (TNFA) Competitors $0.09 -0.01 (-7.60%) Closing price 04:00 PM EasternExtended Trading$0.11 +0.02 (+22.29%) As of 06:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesSEC FilingsTrendsBuy This Stock TNFA vs. ORGS, XBIO, ATNF, CYCC, ENSC, GLTO, KTTA, ALBT, APM, and MTNBShould you be buying TNF Pharmaceuticals stock or one of its competitors? The main competitors of TNF Pharmaceuticals include Orgenesis (ORGS), Xenetic Biosciences (XBIO), 180 Life Sciences (ATNF), Cyclacel Pharmaceuticals (CYCC), Ensysce Biosciences (ENSC), Galecto (GLTO), Pasithea Therapeutics (KTTA), Avalon GloboCare (ALBT), Aptorum Group (APM), and Matinas Biopharma (MTNB). These companies are all part of the "pharmaceutical products" industry. TNF Pharmaceuticals vs. Its Competitors Orgenesis Xenetic Biosciences 180 Life Sciences Cyclacel Pharmaceuticals Ensysce Biosciences Galecto Pasithea Therapeutics Avalon GloboCare Aptorum Group Matinas Biopharma TNF Pharmaceuticals (NASDAQ:TNFA) and Orgenesis (NASDAQ:ORGS) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, valuation, earnings, profitability, risk and media sentiment. Which has stronger valuation and earnings, TNFA or ORGS? TNF Pharmaceuticals has higher earnings, but lower revenue than Orgenesis. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTNF PharmaceuticalsN/AN/A-$23.36M-$6.67-0.01Orgenesis$662K7.54-$55.36MN/AN/A Which has more risk & volatility, TNFA or ORGS? TNF Pharmaceuticals has a beta of 1.98, indicating that its share price is 98% more volatile than the S&P 500. Comparatively, Orgenesis has a beta of 0.47, indicating that its share price is 53% less volatile than the S&P 500. Do insiders & institutionals believe in TNFA or ORGS? 9.6% of TNF Pharmaceuticals shares are held by institutional investors. Comparatively, 22.6% of Orgenesis shares are held by institutional investors. 0.5% of TNF Pharmaceuticals shares are held by company insiders. Comparatively, 5.7% of Orgenesis shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Is TNFA or ORGS more profitable? TNF Pharmaceuticals has a net margin of 0.00% compared to Orgenesis' net margin of -3,827.81%. Orgenesis' return on equity of 0.00% beat TNF Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets TNF PharmaceuticalsN/A -97.38% -37.37% Orgenesis -3,827.81%N/A -130.18% Does the media favor TNFA or ORGS? In the previous week, TNF Pharmaceuticals had 1 more articles in the media than Orgenesis. MarketBeat recorded 1 mentions for TNF Pharmaceuticals and 0 mentions for Orgenesis. TNF Pharmaceuticals' average media sentiment score of 1.24 beat Orgenesis' score of 0.00 indicating that TNF Pharmaceuticals is being referred to more favorably in the media. Company Overall Sentiment TNF Pharmaceuticals Positive Orgenesis Neutral SummaryTNF Pharmaceuticals beats Orgenesis on 6 of the 10 factors compared between the two stocks. Get TNF Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TNFA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TNFA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TNFA vs. The Competition Export to ExcelMetricTNF PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.24M$2.43B$5.49B$9.41BDividend YieldN/A1.79%3.80%4.04%P/E Ratio-0.018.9428.0419.84Price / SalesN/A712.02431.4199.63Price / CashN/A161.2635.8457.94Price / Book0.035.008.125.65Net Income-$23.36M$30.99M$3.25B$258.00M7 Day PerformanceN/A1.69%0.97%2.09%1 Month PerformanceN/A9.20%7.36%11.13%1 Year PerformanceN/A-1.25%31.31%18.40% TNF Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TNFATNF PharmaceuticalsN/A$0.09-7.6%N/AN/A$1.24MN/A-0.016Positive NewsGap DownHigh Trading VolumeORGSOrgenesisN/A$1.18+10.3%N/AN/A$5.66M$662K0.00150XBIOXenetic Biosciences1.3028 of 5 stars$3.66-8.0%N/A-11.1%$5.64M$2.50M-1.544Positive NewsATNF180 Life Sciences0.7935 of 5 stars$0.90-0.7%N/A-21.5%$5.44MN/A-0.067CYCCCyclacel Pharmaceuticals1.2719 of 5 stars$3.31-10.8%N/A-98.0%$5.25M$14K0.0014Gap DownTrading HaltedENSCEnsysce Biosciences0.5698 of 5 stars$2.20+1.9%N/A-69.2%$5.22MN/A-0.3410GLTOGalecto3.6397 of 5 stars$3.90+10.2%$10.00+156.4%-74.5%$5.15MN/A-0.2540KTTAPasithea Therapeutics1.4396 of 5 stars$0.69+0.1%N/A-88.5%$5.14MN/A-0.073ALBTAvalon GloboCare1.3706 of 5 stars$2.71+6.3%N/A-68.0%$5.13M$1.37M-0.145Gap DownHigh Trading VolumeAPMAptorum Group1.5055 of 5 stars$0.95+1.2%N/A-48.7%$5.10M$430K0.0030News CoverageMTNBMatinas BiopharmaN/A$1.00-2.9%N/AN/A$5.09MN/A-0.2130Gap Down Related Companies and Tools Related Companies Orgenesis Alternatives Xenetic Biosciences Alternatives 180 Life Sciences Alternatives Cyclacel Pharmaceuticals Alternatives Ensysce Biosciences Alternatives Galecto Alternatives Pasithea Therapeutics Alternatives Avalon GloboCare Alternatives Aptorum Group Alternatives Matinas Biopharma Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TNFA) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this m...Paradigm Press | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredFREE BUY ALERT: These 3 tiny AI stocks could surgeWe're living in unprecedented times. Most people think it's too late to get into AI right now … That the...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TNF Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TNF Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
